ATLAS / Macro Radar / Reporting / MBRX

Moleculin Biotech, Inc. (MBRX) reporting calendar

Moleculin Biotech, Inc. files periodic reports with the SEC as MBRX on Nasdaq. Atlas tracks 41 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
24 Jul 2026 – 2 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
41

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open MBRX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001437749-26-017034
10-K31 Dec 202518 Mar 202677 days0001437749-26-008841
10-Q30 Sep 202513 Nov 202544 days0001437749-25-034839
10-Q30 Jun 202512 Aug 202543 days0001437749-25-026225
10-Q31 Mar 202513 May 202543 days0001437749-25-016466
10-K31 Dec 202421 Mar 202580 days0001437749-25-008751
10-Q30 Sep 20248 Nov 202439 days0001437749-24-034236
10-Q30 Jun 202413 Aug 202444 days0001437749-24-026367
10-Q31 Mar 202410 May 202440 days0001437749-24-016031
10-K31 Dec 202322 Mar 202482 days0001437749-24-009044
10-Q30 Sep 202313 Nov 202344 days0001437749-23-031391
10-Q30 Jun 202310 Aug 202341 days0001437749-23-023021
10-Q31 Mar 202310 May 202340 days0001437749-23-013582
10-K31 Dec 202222 Mar 202381 days0001437749-23-007537
10-Q30 Sep 202210 Nov 202241 days0001437749-22-026888
10-Q30 Jun 202212 Aug 202243 days0001437749-22-020389
10-Q31 Mar 202211 May 202241 days0001437749-22-011925
10-K31 Dec 202124 Mar 202283 days0001437749-22-007103
10-Q30 Sep 202110 Nov 202141 days0001437749-21-026158
10-Q30 Jun 202111 Aug 202142 days0001437749-21-019445
10-Q31 Mar 202112 May 202142 days0001437749-21-011755
10-K31 Dec 202024 Mar 202183 days0001437749-21-006940
10-Q30 Sep 202012 Nov 202043 days0001437749-20-023605
10-Q30 Jun 202012 Aug 202043 days0001659617-20-000196
10-Q31 Mar 202011 May 202041 days0001659617-20-000128
10-K31 Dec 201919 Mar 202079 days0001659617-20-000066
10-Q30 Sep 201912 Nov 201943 days0001659617-19-000169
10-Q30 Jun 201916 Aug 201947 days0001659617-19-000144
10-Q31 Mar 201913 May 201943 days0001659617-19-000069
10-K31 Dec 201821 Feb 201952 days0001659617-19-000018
10-Q30 Sep 201813 Nov 201844 days0001659617-18-000109
10-Q30 Jun 201810 Aug 201841 days0001659617-18-000093
10-Q31 Mar 201814 May 201844 days0001659617-18-000056
10-K31 Dec 201728 Mar 201887 days0001659617-18-000027
10-Q30 Sep 201713 Nov 201744 days0001659617-17-000005
10-Q30 Jun 201711 Aug 201742 days0001144204-17-042482
10-Q31 Mar 201712 May 201742 days0001144204-17-026918
10-K31 Dec 20163 Apr 201793 days0001144204-17-018352
10-Q30 Sep 201621 Nov 201652 days0001144204-16-135472
10-Q30 Jun 201615 Aug 201646 days0001144204-16-119213

Source: SEC EDGAR company submissions for CIK 0001659617. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.